Neurology and Neurosurgery - Global Neurology Academy

Episodes 17-32 of 43

Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
MinuteCE®
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Jerome A. Barakos, MD
1.25 program credits
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
MinuteCE®
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Jerome A. Barakos, MD
1.25 program credits
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
MinuteCE®
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
1.25 program credits
- James R. Bateman, MD, MPH
- Charles P. Vega, MD
- B. Joy Snider, MD, PhD
1.25 program credits
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
MinuteCE®
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
1.25 program credits
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
1.25 program credits
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
MinuteCE®
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Jerome A. Barakos, MD
1.25 program credits
MinuteCE®
Clinical Conundrums in ARIA: Navigating Case Scenarios in Your Own Practice Setting
1.25 credits 11 episodes
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
- Charles P. Vega, MD
1.25 credits 11 episodes
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
MinuteCE®
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Charles P. Vega, MD
1.25 program credits
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
MinuteCE®
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
1.25 program credits
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
1.25 program credits
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Clinical Conundrums in ARIA: How to Manage Severe ARIA
MinuteCE®
Clinical Conundrums in ARIA: How to Manage Severe ARIA
1.25 program credits
- James R. Bateman, MD, MPH
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
1.25 program credits
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
MinuteCE®
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Jerome A. Barakos, MD
1.25 program credits
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
CME/CE
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
0.25 credits
- Ahmed Z. Obeidat, MD, PhD
0.25 credits
Long-Term Safety of DMTs: What We Know and What We Need to Know
Long-Term Safety of DMTs: What We Know and What We Need to Know
MinuteCE®
Long-Term Safety of DMTs: What We Know and What We Need to Know
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit
MinuteCE®
Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
1.00 credit 10 episodes
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 credit 10 episodes
Balancing Act: Immune Reconstitution vs Immune Suppression
Balancing Act: Immune Reconstitution vs Immune Suppression
MinuteCE®
Balancing Act: Immune Reconstitution vs Immune Suppression
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
MinuteCE®
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit
From Pathology to Practice: The Role of Inflammation in MS Pathology
From Pathology to Practice: The Role of Inflammation in MS Pathology
MinuteCE®
From Pathology to Practice: The Role of Inflammation in MS Pathology
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit

2/3